• Describe how neuroimaging can contribute to understanding women’s elevated risk for Alzheimer’s disease and their typically more aggressive disease progression.
  • Explain how subgroup analyses using functional MRI (fMRI) may help identify individuals who could benefit from anti‑amyloid therapies, even in the context of a negative preclinical clinical trial.
  • Discuss current neurobiological and clinical approaches for determining whether individuals with REM sleep behavior disorder (RBD) are more likely to develop dementia with Lewy bodies versus idiopathic Parkinson’s disease.
Session date: 
03/25/2026 - 8:00am to 9:00am CDT
Location: 
UT Southwestern
Dallas, TX
United States
See map: Google Maps
Add to calendar: 
Please login or create an account to take this course.